Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran
PDF

Keywords

Bulkhorderia cepacia complex
Diagnosis
PFGE

Abstract

Introduction. B. cepacia complex have emerged as an important opportunistic pathogen in hospitalized and immunocompromised patients. Small hospital outbreaks are frequent and are usually due to a single contaminated environmental source. In this study we were going to investigate the role of B.cepacia complex in those patients suspected to involve with cystic fibrosis and evaluate responsible types in Masih Daneshvary Hospital. Methods. One hundred specimens were collected from all admitted patients who were suspected to cystic fibrosis to Masih Daneshvary hospital during one year April 2011 till end of March 2012. All were culture and identified standard procedure. All samples were checked by API system (API20NE) and by specific PCR method for genus Bulkhorderia and Bcc as well. Identified strains were finally tested by PFGE system to identifying specific involving pulse-types. Results. Isolation and identification methods revealed 5 specimens were B.cepasia, The frequency of the cystic fibrosis detected at this study was lower than other similar study previously reported. All these isolates showed similar pattern by PFGE standard protocol that may have spread from a single source and could not be attributed to cross infections from patient to patients. Discussion. Application of PFGE and identification of pulse-type is a potential tool to enhance the investigation of apparent nosocomial outbreaks of B.cepacia. However it needs to be adjusted with environmental findings. Implementation of educational programs and adherence to infection control policies are obviously the main element for complete elimination of an outbreak.
https://doi.org/10.15167/2421-4248/jpmh2014.55.1.422
PDF

References

Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol. 2008;104:1539–1551.

Vanlaere E, Lipuma JJ, Baldwin A, et al. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol. 2008;58:1580–1590.

Chung JW, Altman E, Beveridge TJ, et al. Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun. 2003;71:904–909.

Vanlaere E, Baldwin A, Gevers D, et al. A complex within the Burkholderia cepacia complex comprises at least two novel species: Burkholderia contaminans sp.nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol. 2009;59:102–111.

Reik R, Spilker T, Lipuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol. 2005;43:2926–2928.

Cohen AL, Ridpath A, Noble-Wang J, et al. Outbreak of Serratia marcescens bloodstream and central nervous system infections after interventional pain management procedures. Clin J Pain. 2008;24:374–380.

Pellegrino FL, Schirmer M, Velasco E, et al. Ralstonia pickettii bloodstream infections at a Brazilian cancer institution. Curr Microbiol. 2008;56:219–223.

Grobner S, Heeg P, Autenrieth IB, et al. Monoclonal outbreak of catheter-related bacteraemia by Ralstonia mannitolilytica on two haemato-oncology wards. J Infect. 2007;55:539–544.

Lee HC, Lee NY, Chang CM, et al. Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia. Infect Control Hosp Epidemiol. 2007;28:1213–1217.

Sunenshine RH, Tan ET, Terashita DM, et al. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clin Infect Dis. 2007;45:527–533.

Orsi GB, Villari P, Mondillo V, et al. A plasma expander-related Pseudomonas aeruginosa outbreak. Scand J Infect Dis. 2006;38:1085–1088.

Ghazal SS, Al-Mudaimeegh K, Al Fakihi EM, et al. Outbreak of Burkholderia cepacia bacteremia in immunocompetent children caused by contaminated nebulized sulbutamol in Saudi Arabia. Am J Infect Control. 2006;34:394–398.

Pan A, Dolcetti L, Barosi C, et al. An outbreak of Serratia marcescens bloodstream infections associated with misuse of drug vials in a surgical ward. Infect Control Hosp Epidemiol. 2006;27:79–82.

LiPuma JJ CB, Lum GD, Vandamme PAR. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas and Acidovorax. In: Murray PR BE, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical Microbiology. Washington, DC: ASM Press; 2007. pp. 749–769.

Leite FC, Machado ABMP, Lutz L, et al. Molecular identification of Burkholderia cepacia complex and species distribution among cystic fibrosis patients seen at the reference center in Southern Brazil. Rev HCPA. 2011;31:138–144.

Lynch KH, Dennis JJ. Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol. 2008;46:447–455.

Leite FC, Machado ABMP, Lutz L, et al. Molecular identification of Burkholderia cepacia complex and species distribution among cystic fibrosis patients seen at the reference center in Southern Brazil. Rev HCPA. 2011;31:138–144.

Agodi A, Mahenthiralingam E, Barchitta M, et al. Burkholderia cepacia complex in fection in italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status. J Clin Microbiol. 2001;39:2891–2896.

Drevinek P, Vosahlikova S, Cinek O, et al. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic. J Med Microbiol. 2005;54:655–659.

Kidd TJ, Douglas JM, Bergh HA, et al. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Res Microbiol. 2008;159:194–199.